For this study, we used MCF7 breast cancer and H1299 non-small cell lung cancer cells that have low intrinsic RAB4A expression and low baseline replating sphere formation ability (Fig. 6E–H). This evidence concerns the gene RAB4A and non-small cell lung carcinoma.